Riskpilot← Back to searchSign inGet full accessRefine & Nurse AB
ABActiveOrg 5592423627Fredsgatan 13Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20200 employees
Revenue 2025
SEK 606K
+4% vs 2024
EBITDA margin
2.6%
+108% vs 2024
Equity ratio
-44.7%
Financial strength
Net profit 2025
SEK 1K
+101% vs 2024
| Revenue | SEK 606K | +4% |
| EBITDA | SEK 16K | +108% |
| Net profit | SEK 1K | +101% |
| Total assets | SEK 167K | -47% |
| Equity | SEK -75K | +2% |
| Employees | 0 | — |
Legal name
Refine & Nurse AB
Org number
5592423627
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
13 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet av personlig utveckling i form avyoga/meditation eller andra aktiviteter, uthyrning av personal och tjänster inom sjukvården, förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Fredsgatan 13
Email
refineyourskill@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 172 | 566 | 707 | 580 | 606 |
| Staff expenses | — | — | −600 | −662 | −447 |
| EBITDA | 123 | 192 | 66 | −197 | 16 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 123 | 192 | 66 | −197 | 16 |
| Net financials | — | — | 0 | −6 | −15 |
| Profit before tax | 124 | 192 | 66 | −203 | 1 |
| Tax | −27 | −40 | −14 | — | — |
| Net profit | 97 | 152 | 53 | −203 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 201 | 519 | 465 | 312 | 167 |
| Equity | 122 | 274 | 227 | −76 | −75 |
| Long-term debt | 0 | 0 | — | 196 | 88 |
| Short-term debt | 79 | 244 | 239 | 192 | 153 |
| Total debt | 79 | 244 | 239 | 388 | 241 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20212025
Equity ratio
-44.7%
This company
38.2%
Market median
-217% vs market
20212025
Return on equity
125700.0%
This company
18.4%
Market median
+683052% vs market
20212025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20212025
Asset turnover
3.64×
This company
1.12×
Market median
+225% vs market
20212025
Debt / equity
3.23×
This company
0.62×
Market median
-421% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Refine & Nurse AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Elisabet Carlsson | Deputy Board Member | 0 companies |
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |
| Marie Charlotte Carlsson | Board of Directors | 0 companies |